Patents by Inventor Vicente Emilio LARRAGA RODRÍGUEZ DE VERA

Vicente Emilio LARRAGA RODRÍGUEZ DE VERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecular adjuvant and vaccine
    Patent number: 11179462
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Grant
    Filed: January 16, 2020
    Date of Patent: November 23, 2021
    Assignees: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS, CZ VETERINARIA S.A.
    Inventors: Pedro José Alcolea Alcolea, Ana María Alonso Ayala, Vicente Emilio Larraga Rodríguez De Vera
  • MOLECULAR ADJUVANT AND VACCINE
    Publication number: 20200360512
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Application
    Filed: January 16, 2020
    Publication date: November 19, 2020
    Inventors: Pedro José ALCOLEA ALCOLEA, Ana María ALONSO AYALA, Vicente Emilio LARRAGA RODRÍGUEZ DE VERA
  • MOLECULAR ADJUVANT AND VACCINE
    Publication number: 20180289796
    Abstract: The invention relates to the fields of vaccines and vaccine adjuvants, and generally relates to polynucleotide adjuvants, polynucleotide vaccines and vaccine compositions. More specifically, the invention relates to said polynucleotides and vaccine compositions for use in inducing or enhancing a prophylactic or therapeutic immune response in a mammalian subject. Furthermore, it relates to said polynucleotides and vaccine compositions for use in the prophylactic or therapeutic treatment of an infectious disease, such as in the prophylactic or therapeutic treatment of leishmaniasis.
    Type: Application
    Filed: May 23, 2016
    Publication date: October 11, 2018
    Inventors: Pedro José ALCOLEA ALCOLEA, Ana María ALONSO AYALA, Vicente Emilio LARRAGA RODRÍGUEZ DE VERA
  • Vaccine to protect animals against leishmania
    Patent number: 8986711
    Abstract: The present invention is generally related to the prevention of leishmaniasis in animals, particularly infection caused by Leishmania sp., based on the use of Leishmania infantum P36 protein or an immunogenic fragment of the latter, or involving an expression system for the mentioned protein or fragment—optionally in combination with a compound stimulating the production of a Th1-type cellular immune response—and comprising various vaccination protocols in application to Leishmania sp. based on the mentioned vaccine.
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: March 24, 2015
    Assignees: Consejo Superior de Investigaciones Cientificas, Universidad de Zaragoza, Laboratorios Hipra, S.A.
    Inventors: Vicente Emilio Larraga Rodriguez De Vera, Gloria Gonzalez Aseguinolaza, Maria Jesus Ramiro Ibanez, Juan Antonio Castillo Hernandez, Javier Lucientes Curdi
  • Vaccine to protect animals against leishmania
    Publication number: 20040156866
    Abstract: The present invention is generally related to the prevention of leishmaniasis in animals, particularly infection caused by Leishmania sp., based on the use of Leishmania infantum P36 protein or an immunogenic fragment of the latter, or involving an expression system for the mentioned protein or fragment—optionally in combination with a compound stimulating the production of a Th1-type cellular immune response—and comprising various vaccination protocols in application to Leishmania sp. based on the mentioned vaccine.
    Type: Application
    Filed: March 16, 2004
    Publication date: August 12, 2004
    Inventors: Vicente Emilio Larraga Rodriguez De Vera, Gloria Gonzalez Aseguinolaza, Maria Jesus Ramiro Ibanez, Juan Antonio Castillo Hernandez, Javier Lucientes